Global Blood Therapeutics Investor Relations Material
Latest events
Investor Conference 2022
Global Blood Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Global Blood Therapeutics Inc
Access all reports
Global Blood Therapeutics Inc. is a biopharmaceutical company focused on developing and delivering treatments for blood disorders. The company is primarily known for its work in addressing sickle cell disease, offering innovative therapies aimed at improving the quality of life for patients suffering from this and other blood-related conditions. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
GBT
Country
🇺🇸 United States